Ian H. de Boer, Rajnish Mehrotra Kidney International

Slides:

Advertisements

Similar presentations

A phase 2 study on the treatment of hyperkalemia in patients with chronic kidney disease suggests that the selective potassium trap, ZS-9, is safe and.

Advertisements

Volume 83, Issue 2, Pages (February 2013)

Ischemic heart disease after renal transplantation

LDL cholesterol in CKD—to treat or not to treat?

Volume 14, Issue 2, Pages (August 2011)

Ghrelin—a new player in glucose homeostasis?

Volume 70, Issue 3, Pages (August 2006)

Anemia management in chronic kidney disease

KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update

Volume 79, Issue 9, Pages (May 2011)

Volume 83, Issue 3, Pages (March 2013)

Lipopheresis in the nephrotic syndrome

ESA and iron therapy in chronic kidney disease: a balance between patient safety and hemoglobin target Szu-Chun Hung, Der-Cherng Tarng Kidney International

Shining light on vitamin D trials in chronic kidney disease

Status of chronic kidney disease prevention programs: International Federation of Kidney Foundation Members 2005/2007 Joanna M. Smith, Susan A. Mott,

Reassessment of the care of the patient with chronic kidney disease

John P. Middleton, Patrick H. Pun Kidney International

Susumu Takahashi, Kazuyoshi Okada, Mitsuru Yanai Kidney International

Jeffrey C. Fink, Glenn M. Chertow Kidney International

Comorbidity and confounding in end-stage renal disease

The importance of increased dialysis and anemia management for infant survival in pregnant women on hemodialysis Sai Subhodhini Reddy, Jean L. Holley

Volume 74, Issue 3, Pages (August 2008)

The new role of calcimimetics as vasculotropic agents

Lipid redistribution in renal dysfunction

Volume 70, Issue 11, Pages (December 2006)

Severe exfoliative skin rash with icodextrin

Volume 86, Issue 2, Pages (August 2014)

The epidemiology of chronic kidney disease

Use of vitamin D in chronic kidney disease patients

Volume 87, Issue 2, Pages (February 2015)

Correction to "Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate.

LDL cholesterol in CKD—to treat or not to treat?

Kenar D. Jhaveri, Steven Fishbane Kidney International

Ferruh Artunc, Friedhelm Hildebrandt, Kerstin Amann

Volume 73, Issue 12, Pages (June 2008)

Volume 87, Issue 1, Pages (January 2015)

A physician's perseverance uncovers problems in a key nephrology study

Extracorporeal therapy in sepsis: are we there yet?

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Tilman B. Drüeke, Ziad A. Massy Kidney International

Methods for guideline development

Volume 87, Issue 1, Pages (January 2015)

Extracorporeal removal of toxins

Volume 67, Issue 4, Pages (April 2005)

Volume 76, Issue 9, Pages (November 2009)

The global challenge of chronic kidney disease

Nephrology Crossword: Glomerulonephritis

Volume 14, Issue 2, Pages (August 2011)

Insulin resistance and hypertension: new insights

Circadian regulation of renal function

A man with a hole in his penis

Mediterranean diets: are they practical in the Western world?

Vitamin D in chronic kidney disease: is the jury in?

Cardio-Kidney-Damage: a unifying concept

Volume 72, Issue 2, Pages (July 2007)

Volume 80, Issue 10, Pages (November 2011)

The hypothesis that abnormal BH4 metabolism impairs kidney function

Is complement a target for therapy in renal disease?

Volume 70, Issue 3, Pages (August 2006)

Tobias Breidthardt, Alexandre Mebazaa, Christian E. Mueller

Miguel G. Salom, Bárbara Bonacasa Kidney International

Ischemic heart disease after renal transplantation

Hisataka Kobayashi, Peter L. Choyke Kidney International

The international realities of live donor kidney transplantation

In chronic kidney disease staging the use of the chronicity criterion affects prognosis and the rate of progression B.O. Eriksen, O.C. Ingebretsen Kidney.

Prevention of vascular calcification with bisphosphonates without affecting bone mineralization: a new challenge? Ellen G. Neven, Marc E. De Broe, Patrick.

Volume 74, Issue 10, Pages (November 2008)

Volume 76, Issue 2, Pages (July 2009)

Sugar-sweetened beverages and chronic disease

Presentation transcript:

Insulin resistance in chronic kidney disease: a step closer to effective evaluation and treatment Ian H. de Boer, Rajnish Mehrotra Kidney International Volume 86, Issue 2, Pages 243-245 (August 2014) DOI: 10.1038/ki.2014.123 Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 1 Selected actions of insulin. Insulin is a key regulator of glucose homeostasis through effects on liver, muscle, and adipose tissue (shaded area). Insulin also affects other organs and tissues. Decreased sensitivity of target organs to insulin—or insulin resistance—leads to impaired glucose homeostasis and dysfunction of other insulin-sensitivity organs. HDL, high-density lipoprotein; LDL, low-density lipoprotein. Kidney International 2014 86, 243-245DOI: (10.1038/ki.2014.123) Copyright © 2014 International Society of Nephrology Terms and Conditions